P

Inventor

SNIDER JAMES V

US35 patents
⚠️ This page may combine multiple inventors who share the name “SNIDER JAMES V”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CRITICAL CARE DIAGNOSTICS INC

28 patents
US7998683B2Aug 16, 2011

Predicting mortality and detecting severe disease

CRITICAL CARE DIAGNOSTICS INC46 citations97
US9239333B2Jan 19, 2016

Methods of determining efficacy of treatment in a subject having heart failure

CRITICAL CARE DIAGNOSTICS INC26 citations94
USD800332SOct 17, 2017

Blood test kit

CRITICAL CARE DIAGNOSTICS INC22 citations92
US9150654B2Oct 6, 2015

Soluble human ST-2 antibodies and assays

CRITICAL CARE DIAGNOSTICS INC14 citations92
US9057733B2Jun 16, 2015

Predicting mortality and detecting severe disease

CRITICAL CARE DIAGNOSTICS INC15 citations92
USD800333SOct 17, 2017

Blood test kit

CRITICAL CARE DIAGNOSTICS INC19 citations90
USD770057SOct 25, 2016

Blood test kit

CRITICAL CARE DIAGNOSTICS INC20 citations90
US9523696B2Dec 20, 2016

Methods for predicting risk of developing hypertension

CRITICAL CARE DIAGNOSTICS INC13 citations84
US10303844B2May 28, 2019

Multimarker risk stratification

CRITICAL CARE DIAGNOSTICS INC6 citations83
US9551708B2Jan 24, 2017

Methods of treating a subject having heart failure

CRITICAL CARE DIAGNOSTICS INC8 citations82
US10745484B2Aug 18, 2020

Soluble human ST-2 antibodies and assays

CRITICAL CARE DIAGNOSTICS INC1 citations73
US10408845B2Sep 10, 2019

Methods for treating or predicting risk of a ventricular tachyarrhythmia event

CRITICAL CARE DIAGNOSTICS INC4 citations68
US9823257B2Nov 21, 2017

Methods of treating or selecting a treatment for a subject having heart failure that include detecting levels of galectin-3 and soluble ST2

CRITICAL CARE DIAGNOSTICS INC1 citations63
US11016103B2May 25, 2021

Predicting mortality and detecting severe disease

CRITICAL CARE DIAGNOSTICS INC0 citations62
US10067146B2Sep 4, 2018

Predicting mortality and detecting severe disease

CRITICAL CARE DIAGNOSTICS INC1 citations62
US10928393B2Feb 23, 2021

Methods of treating cardiovascular diseases and predicting the efficacy of exercise therapy

CRITICAL CARE DIAGNOSTICS INC0 citations61
US10741290B2Aug 11, 2020

Multimarker risk stratification

CRITICAL CARE DIAGNOSTICS INC1 citations61
US11170896B2Nov 9, 2021

Predicting risk of major adverse cardiac events

CRITICAL CARE DIAGNOSTICS INC0 citations60
US9965593B2May 8, 2018

Predicting risk of major adverse cardiac events

CRITICAL CARE DIAGNOSTICS INC1 citations60
US9886553B2Feb 6, 2018

Predicting risk of major adverse cardiac events

CRITICAL CARE DIAGNOSTICS INC1 citations60
US11525828B2Dec 13, 2022

Test apparatus and methods for ST2 cardiac biomarker

CRITICAL CARE DIAGNOSTICS INC0 citations59
US11340222B2May 24, 2022

Test apparatus and methods for ST2 cardiac biomarker

CRITICAL CARE DIAGNOSTICS INC0 citations59
US10325682B2Jun 18, 2019

Test apparatus and methods for ST2 cardiac biomarker

CRITICAL CARE DIAGNOSTICS INC1 citations59
US10324089B2Jun 18, 2019

Test apparatus and methods for ST2 cardiac biomarker

CRITICAL CARE DIAGNOSTICS INC1 citations59
US11340236B2May 24, 2022

Methods for treating or predicting risk of a ventricular tachyarrhythmia event

CRITICAL CARE DIAGNOSTICS INC0 citations57
US10393756B2Aug 27, 2019

Methods of treating a subject having heart failure that include detecting levels of galectin-3 and soluble ST2

CRITICAL CARE DIAGNOSTICS INC0 citations52
US10041957B2Aug 7, 2018

Methods for predicting risk of developing hypertension

CRITICAL CARE DIAGNOSTICS INC1 citations52
US10079073B2Sep 18, 2018

Test apparatus and methods for ST2 cardiac biomarker

CRITICAL CARE DIAGNOSTICS INC1 citations48

SNIDER JAMES V

7 patents